Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03752333
Title Trial of Pembrolizumab in Cancer of Unknown Primary (CUPem)
Acronym CUPem
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Imperial College London
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR

Facility Status City State Zip Country Details
Hammersmith Hospital London W12 0HS United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field